PE-backed Verscend acquires Cotiviti

Verscend, a portfolio company of Veritas Capital, has acquired Cotiviti Holdings Inc, a provider of payment accuracy and analytics-driven solutions focused primarily on the healthcare industry. According to terms of the deal, Cotiviti shareholders will receive $44.75 in cash for each share of Cotiviti common stock they hold. As a result of the closing, Cotiviti has been delisted from the New York Stock Exchange.

DealsNorth AmericaUSHealthcareBriefs